最新の財務諸表(Form-10K)によると、Orthofix Medical Incの総資産は$0で、純損失は$0です。
OFIXの主要な財務比率は何ですか?
Orthofix Medical Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Orthofix Medical Incの収益はセグメントまたは地域別にどのように分けられていますか?
Orthofix Medical Inc の最大収益セグメントは Spinal Implants, Biologics, and Enabling Technologies で、最新の利益発表における収益は 418,789,000 です。地域別に見ると、United States が Orthofix Medical Inc の主要市場であり、収益は 620,829,000 です。
Orthofix Medical Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Orthofix Medical Incの純損失は$0です。
Orthofix Medical Incに負債はありますか?
いいえ、Orthofix Medical Incの負債は0です。
Orthofix Medical Incの発行済株式数は何株ですか?
Orthofix Medical Incの総発行済株式数は0株です。
主要データ
前終値
$9.23
始値
$9.9
当日レンジ
$9.18 - $9.9
52週レンジ
$9.5 - $16.99
取引高
443.7K
平均取引高
296.1K
配当利回り
--
1株当たり利益(TTM)
-1.50
時価総額
$386.0M
OFIXとは何ですか?
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,605 full-time employees. The company offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The company provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.